Folder: entities

Apr 19, 2026

• vector
• mosquito
• Aedes-aegypti
• transmission
• urban
• salivary-gland
• DENV-2
• Asian-genotype

Apr 19, 2026

• serotype
• DENV-1
• epidemiology
• secondary-infection
• ADE
• Singapore
• Nicaragua
• antibody-kinetics
• anti-prM
• cross-reactivity
• NS1-levels
• viraemia

Apr 19, 2026

• serotype
• DENV-3
• Cuba
• displacement
• epidemic-dynamics
• CNS-invasion
• neuropathogenesis
• Singapore
• Taiwan
• Nicaragua
• anti-platelet
• IgM
• primary-infection
• antibody-kinetics
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity

Apr 19, 2026

• NS1
• non-structural-protein
• molecular-mimicry
• autoimmunity
• platelet
• endothelial-cell
• coagulation
• vaccine
• DHF
• flavivirus
• antibody-kinetics
• waning
• type-specific
• IgM
• IgG
• primary-infection
• secondary-infection
• platelet-lysis
• complement
• PAIgG
• immune-complex
• replication-complex
• MIF
• autophagy
• cathepsin-L
• heparanase
• P311-330
• PDI
• epitope-mapping
• thrombomodulin
• Vietnam
• infants
• isotype-shift

Apr 18, 2026

• vector
• Aedes-albopictus
• secondary-vector
• Europe
• USA
• invasion
• C6-36-cell-line

Apr 18, 2026

• E-protein
• envelope-protein
• structural-protein
• receptor-binding
• vaccine-target
• fusion
• neutralising-antibody
• WGNGCG
• coagulation
• EDI-II
• EDIII
• cross-reactive
• longitudinal
• IgG-kinetics
• anti-prM
• structural-antibody-proportion

Apr 17, 2026

• serotype
• DENV-2
• Asian-genotype
• virulence
• ADE
• secondary-infection
• Cuba
• CNS-invasion
• neuropathogenesis
• anti-platelet
• IgM
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity
• NS3
• salivary-gland-replication

Apr 17, 2026

• serotype
• DENV-4
• Cuba
• epidemic
• autoantibody-cross-serotype
• anti-prM
• cross-reactivity

Apr 17, 2026

• Fc-receptor
• FcgRIIa
• genetics
• polymorphism
• immune-complex
• leukocyte
• IgG-affinity
• SPR
• IgG2
• inhibitory-receptor
• FcgRIIB
• thrombocytopenia
• PAIgG
• PAIgM
• FcR-bypass

Apr 17, 2026

• prM
• pre-membrane-protein
• structural-protein
• virion-maturation
• ADE
• furin-cleavage
• immature-virion
• cross-reactive
• vaccine-design
• molecular-mimicry
• HSP60

Apr 12, 2026

• vaccine
• CYD-TDV
• Dengvaxia
• Sanofi-Pasteur
• ADE
• seronegative
• phase-III
• live-attenuated
• ChimeriVax
• tetravalent

Apr 12, 2026

• vector-control
• Wolbachia
• biological-control
• Aedes-aegypti
• sustainable-control
• wMel